These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1748066)

  • 21. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.
    Nishimura C; Saito T; Ito T; Omori Y; Tanimoto T
    Diabetologia; 1994 Mar; 37(3):328-30. PubMed ID: 8174849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Song HP; Han XY; He Y; Kang TB; Wu HW
    Chin Med J (Engl); 1991 Oct; 104(10):818-24. PubMed ID: 1661222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microdetermination of aldose and aldehyde reductases from human tissues.
    Song HP; Das B; Srivastava SK
    Curr Eye Res; 1987 Aug; 6(8):1001-6. PubMed ID: 3117493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
    Hotta N; Kakuta H; Koh N; Fukasawa H; Yasuma T; Awaya S; Sakamoto N
    Diabetes Res Clin Pract; 1991 Oct; 14(1):29-35. PubMed ID: 1748061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Fluoro-3-deoxy-D-galactose: a new probe for studies on sugar cataract.
    Secchi EF; Lizak MJ; Sato S; Kador PF
    Curr Eye Res; 1999 Apr; 18(4):277-82. PubMed ID: 10372987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme immunoassay for erythrocyte aldose reductase.
    Nishimura C; Hamada Y; Tachikawa T; Ishikawa T; Gui T; Tsubouchi J; Hotta N; Tanimoto T; Urakami T
    Clin Chem; 1994 Jun; 40(6):889-94. PubMed ID: 8087983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
    Tsukushi S; Katsuzaki T; Aoyama I; Takayama F; Miyazaki T; Shimokata K; Niwa T
    Kidney Int; 1999 May; 55(5):1970-6. PubMed ID: 10231461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feedback inhibition of aldose reductase gene expression in rat renal medulla. Galactitol accumulation reduces enzyme mRNA levels and depletes cellular inositol content.
    Bondy C; Cowley BD; Lightman SL; Kador PF
    J Clin Invest; 1990 Oct; 86(4):1103-8. PubMed ID: 2120282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial cell density in cataractous lenses of patients with diabetes: association with erythrocyte aldose reductase.
    Kumamoto Y; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
    Exp Eye Res; 2007 Sep; 85(3):393-9. PubMed ID: 17655844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term hyperglycaemia of oral glucose on red cell sorbitol and plasma glucose concentrations in diabetic and non-diabetic Nigerians.
    Anaja HP
    Cent Afr J Med; 1995 Jun; 41(6):199-202. PubMed ID: 7664326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy.
    Nishimura C; Hotta Y; Gui T; Seko A; Fujimaki T; Ishikawa T; Hayakawa M; Kanai A; Saito T
    Diabetes Res Clin Pract; 1997 Sep; 37(3):173-7. PubMed ID: 9306038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney.
    Sato S
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F799-805. PubMed ID: 1443170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.
    Chandra D; Jackson EB; Ramana KV; Kelley R; Srivastava SK; Bhatnagar A
    Diabetes; 2002 Oct; 51(10):3095-101. PubMed ID: 12351453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in sorbitol accumulation and polyol-pathway activity in cultured human proximal tubule cells.
    Flath MC; Bylander JE; Sens DA
    Diabetes; 1992 Sep; 41(9):1050-5. PubMed ID: 1499857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of galactose feeding on aldose reductase gene expression.
    Wu RR; Lyons PA; Wang A; Sainsbury AJ; Chung S; Palmer TN
    J Clin Invest; 1993 Jul; 92(1):155-9. PubMed ID: 8325980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications].
    Nishimura-Yabe C
    Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):137-45. PubMed ID: 9583077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.